Brands like Kourtney Kardashian's Lemme are claiming to provide the same benefits as GLP-1 medications like Ozempic, Wegovy, ...
It took GLP-1 medications like Ozempic just seven years to surpass insulin as the the second most common treatment for type 2 ...
In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and ...
Glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) are entero-pancreatic hormone-based treatments first approved in 2005 for type 2 diabetes (T2D). They are now commonly prescribed for weight ...
GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...
Glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, have dominated headlines for their ...
GlobalData on MSN1d
Social media algorithms are driving the the GLP-1 drugs boomGLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...
Results of a recent study found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a lower risk ...
People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...
It took GLP-1 medications like Ozempic just seven years to surpass insulin as the the second most common treatment for type 2 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback